Statistics for Helix Biopharma Corp (id:13824 HBP)
Valuation metrics
Market cap
47.55M
Enterprise value
45.49M
Trailing P/E (ttm)
Forward P/E
-8.82
PEG ratio
-8.82
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA
-4.93
Overview
Shares outstanding
49.02M
Float
44.04M
Shares short
2.60K
% Held by insiders
5.00%
% Held by institutions
0.00%
Average volume (10 days)
4.13K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
1.35
52-Week change
-8.25%
Beta
3.00
50-Day moving average
3.00
200-Day moving average
1.06
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
August 16, 2024
Financials
Fiscal yearFiscal year ends
July 31, 2024
Most recent quarter (mrq)
July 31, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-458.65%
Return on equity
10.29K%
Income statement
Revenue (ttm)
Revenue per share (ttm)
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-9,225,000.00
Net income to common (ttm)
-9,264,000.00
Diluted EPS (ttm)
-1.05
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.08M
Total cash per share (mrq)
5.00
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
92.20%
Book value per share (mrq)
5.00
Cash flow
Cash flow statement
-5,219,000.00
Levered free cash flow (LFCF)
-2,745,750.00